Ron Bentsur insider trades
Open-market stock purchases and sales by Ron Bentsur, Chairman & CEO at Nuvectis Pharma, Inc, from SEC Form 4 filings since Jan 2, 2010.
Track record: 40% of 77 scored buys are up 5% or more since purchase, averaging -4%.
Open-market stock purchases and sales by Ron Bentsur, Chairman & CEO at Nuvectis Pharma, Inc, from SEC Form 4 filings since Jan 2, 2010.
Track record: 40% of 77 scored buys are up 5% or more since purchase, averaging -4%.